Background illustration for clinical trials search

Paid Clinical Trials Bronx

Discover 4,047 paid clinical trials in Bronx, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radiculopathy

for
Radiculopathy Lumbar, Radiculopathy Sacral,
Location: Astoria NY, Queens Village NY, Hicksville NY,
Sponsor: NeuFit - Neurological Fitness and Education

Sex: All

Age: 18+

Code: NCT06421558

Recruiting

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

for
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease,
Location: New York NY
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 50+

Code: NCT07553338

Phase 2, Recruiting

Evaluation of the Safety and Efficacy of the NuEra Tight VRF for the Treatment of Vaginal and Vulvar Tissue Laxity

for
Vagina Atrophy
Location: New York NY
Sponsor: Lumenis Be Ltd.

Sex: Female

Age: 35 - 60

Code: NCT04511260

Recruiting

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

for
Advanced NRAS-Mutant Melanoma,
Location: New York NY, Boston MA, Fairfax VA, Grand Rapids MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07584226

Phase 1, Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)

for
Irritable Bowel Syndrome, Constipation
Location: New York NY, Providence RI, Scarborough, Stouffville,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07545772

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System

for
Venous Embolism of Lower Extremities (Diagnosis),
Location: New York NY, Washington D.C. DC, Naples FL, Plano TX
Sponsor: Medtronic Endovascular

Sex: All

Age: 22+

Code: NCT07335341

Recruiting

A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: New York NY, Jacksonville FL, Gainesville FL, Dallas TX,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT07759128

Phase 3, Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: New York NY, Brooklyn NY, Toms River NJ, Farmington CT,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase 3, Recruiting

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

for
Meningioma
Location: New York NY, Providence RI, Boston MA, Fairfax VA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07428616

Phase 2, Recruiting

A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

for
Pneumococcal Disease
Location: Valhalla NY, Hawthorne NY, Fall River MA, Sayre PA,
Sponsor: Pfizer

Sex: All

Age: 0

Code: NCT07573462

Phase 3, Recruiting

The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment

for
Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21),
Location: New York NY, Atlanta GA, Sarasota FL, Baton Rouge LA,
Sponsor: BillionToOne Inc.

Sex: Female

Age: 0+

Code: NCT07643896

Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: New York NY, North Worcester MA, Foxborough MA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase 3, Recruiting

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: New York NY, Carmel NY, Hamden CT, New Bedford MA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07499232

Phase 3, Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

for
B-cell Mediated Autoimmune Disorders
Location: New York NY, Rochester NY, Cleveland OH, Columbus OH,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06680037

Phase 1, Recruiting

A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours

for
Solid Tumours
Location: New York NY, Valhalla NY, Philadelphia PA, Fairfax VA,
Sponsor: Orion Corporation, Orion Pharma

Sex: All

Age: 18+

Code: NCT06725758

Phase 1, Phase 2, Recruiting

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

for
Metastatic Colorectal Cancer
Location: White Plains NY, Newport News VA, Ottawa, Toronto,
Sponsor: EMD Serono Research & Development Institute, Inc.

Sex: All

Age: 18+

Code: NCT07549412

Phase 3, Recruiting

A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

for
Depressive Disorder, Treatment-Resistant
Location: New York NY, Cedarhurst NY, Skokie IL, Marietta GA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07716098

Phase 3, Recruiting

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

for
Major Depressive Disorder
Location: New York NY, Brooklyn NY, Staten Island NY,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06223880

Recruiting

A Study of Ivonescimab in People With Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: New York NY, Harrison NY, Uniondale NY, Montvale NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07594522

Phase 1, Phase 2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for
B-cell Malignancies
Location: New York NY, Hackensack NJ, Montreal, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase 1, Phase 2, Recruiting